• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: a case report from Spain.

作者信息

López-Rojas Rafael, Jiménez-Mejías Manuel Enrique, Lepe José Antonio, Pachón Jerónimo

出版信息

J Infect Dis. 2011 Oct 1;204(7):1147-8. doi: 10.1093/infdis/jir476.

DOI:10.1093/infdis/jir476
PMID:21881133
Abstract
摘要

相似文献

1
Acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: a case report from Spain.对黏菌素耐药的鲍曼不动杆菌改变其抗生素耐药谱：来自西班牙的病例报告。
J Infect Dis. 2011 Oct 1;204(7):1147-8. doi: 10.1093/infdis/jir476.
2
Acinetobacter baumannii resistant to colistin with impaired virulence: a case report from France.一株对黏菌素耐药且毒力受损的鲍曼不动杆菌：来自法国的病例报告。
J Infect Dis. 2011 Oct 1;204(7):1146-7. doi: 10.1093/infdis/jir475.
3
Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii.舒巴坦与黏菌素联合对耐黏菌素鲍曼不动杆菌的协同活性。
Int J Antimicrob Agents. 2012 Feb;39(2):180-1. doi: 10.1016/j.ijantimicag.2011.10.001. Epub 2011 Nov 17.
4
Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii.在一名患有广泛耐药鲍曼不动杆菌的患者中，长期使用黏菌素后出现黏菌素耐药性，但适应性和毒力未丧失。
Diagn Microbiol Infect Dis. 2015 Jul;82(3):222-6. doi: 10.1016/j.diagmicrobio.2015.03.013. Epub 2015 Mar 25.
5
Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii.粘菌素耐药鲍曼不动杆菌毒力和体内适应性受损。
J Infect Dis. 2011 Feb 15;203(4):545-8. doi: 10.1093/infdis/jiq086. Epub 2011 Jan 7.
6
Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii.E试验法检测鲍曼不动杆菌临床分离株对黏菌素耐药性的可靠性
J Clin Microbiol. 2005 Feb;43(2):903-5. doi: 10.1128/JCM.43.2.903-905.2005.
7
Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.鲍曼不动杆菌因脂多糖丢失导致的粘菌素耐药表型改变。
Virulence. 2018 Dec 31;9(1):930-942. doi: 10.1080/21505594.2018.1460187.
8
Colistin-resistant Acinetobacter baumannii ventilator-associated pneumonia in a tertiary care hospital: an evolving threat.三级医院中耐黏菌素鲍曼不动杆菌所致呼吸机相关性肺炎：一种不断演变的威胁
J Hosp Infect. 2016 Sep;94(1):72-3. doi: 10.1016/j.jhin.2016.04.014. Epub 2016 May 6.
9
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.几种抗菌肽对多黏菌素敏感和多黏菌素耐药鲍曼不动杆菌的体外活性。
Clin Microbiol Infect. 2012 Apr;18(4):383-7. doi: 10.1111/j.1469-0691.2011.03581.x. Epub 2011 Jun 14.
10
Intensified infection control measures to minimize the spread of colistin-resistant Acinetobacter baumannii.强化感染控制措施，以尽量减少耐黏菌素鲍曼不动杆菌的传播。
Infect Control Hosp Epidemiol. 2013 Apr;34(4):445-7. doi: 10.1086/669959.

引用本文的文献

1
Synergistic action between peptide-neomycin conjugates and polymyxin B against multidrug-resistant gram-negative pathogens.肽-新霉素偶联物与多粘菌素B对多重耐药革兰氏阴性病原体的协同作用。
Front Microbiol. 2025 Aug 7;16:1605813. doi: 10.3389/fmicb.2025.1605813. eCollection 2025.
2
The Genetic Background and Culture Medium Only Marginally Affect the In Vitro Evolution of Toward Colistin Resistance.遗传背景和培养基对多黏菌素耐药性体外进化的影响微乎其微。
Antibiotics (Basel). 2025 Jun 13;14(6):601. doi: 10.3390/antibiotics14060601.
3
Development, Characterization, and Antimicrobial Evaluation of Hybrid Nanoparticles (HNPs) Based on Phospholipids, Cholesterol, Colistin, and Chitosan Against Multidrug-Resistant Gram-Negative Bacteria.
基于磷脂、胆固醇、黏菌素和壳聚糖的杂化纳米颗粒（HNPs）对多重耐药革兰氏阴性菌的研制、表征及抗菌评估
Pharmaceutics. 2025 Feb 1;17(2):182. doi: 10.3390/pharmaceutics17020182.
4
Colistin Resistance Mechanism and Management Strategies of Colistin-Resistant Infections.黏菌素耐药机制及耐黏菌素感染的管理策略
Pathogens. 2024 Nov 28;13(12):1049. doi: 10.3390/pathogens13121049.
5
Cyclic Peptide MV6, an Aminoglycoside Efficacy Enhancer Against .环肽MV6，一种针对……的氨基糖苷类增效剂
Antibiotics (Basel). 2024 Dec 1;13(12):1147. doi: 10.3390/antibiotics13121147.
6
Discovery of new antimicrobial thiophene derivatives with activity against drug-resistant Gram negative-bacteria.发现对耐药革兰氏阴性菌具有活性的新型抗菌噻吩衍生物。
Front Pharmacol. 2024 Aug 20;15:1412797. doi: 10.3389/fphar.2024.1412797. eCollection 2024.
7
A New Pharmacokinetic-Pharmacodynamic Model To Characterize the Inoculum Effect of Acinetobacter baumannii on Polymyxin B .一种新的药代动力学-药效学模型来描述鲍曼不动杆菌对多粘菌素 B 的接种效应。
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0178921. doi: 10.1128/AAC.01789-21. Epub 2021 Nov 15.
8
Antimicrobial Resistance Mechanisms and Virulence of Colistin- and Carbapenem-Resistant Isolated from a Teaching Hospital in Taiwan.从台湾一家教学医院分离出的对黏菌素和碳青霉烯耐药菌株的抗菌耐药机制及毒力
Microorganisms. 2021 Jun 14;9(6):1295. doi: 10.3390/microorganisms9061295.
9
Cerebrospinal fluid (CSF) augments metabolism and virulence expression factors in Acinetobacter baumannii.脑脊髓液 (CSF) 增强鲍曼不动杆菌的代谢和毒力表达因子。
Sci Rep. 2021 Feb 26;11(1):4737. doi: 10.1038/s41598-021-81714-6.
10
Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report.耐黏菌素鲍曼不动杆菌分离株引起的菌血症：一例报告。
J Med Case Rep. 2019 May 8;13(1):141. doi: 10.1186/s13256-019-2062-3.